Original Articles
21 June 2025
Vol. 60 No. 1 (2008)
https://doi.org/10.4081/reumatismo.2008.22

Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
1154
Views
945
Downloads

Authors

S. Zingarelli
office@pagepress.org
P. Airò
M. Frassi
C. Bazzani
M. Scarsi
M. Puoti
Hepatitis B virus (HBV) is a DNA virus transmitted predominantly by sexual contact or percutaneous exposure. HBV infection is by far the most common chronic viral infection affecting the liver in the world, and a leading cause of cirrhosis and hepatocellular carcinoma. Reactivation of HBV replication in patients undergoing immunosuppressive therapy is a well recognised and frequently reported complication of considerable clinical importance. The consequences of hepatic injury in these patients may range from asymptomatic liver function disturbances to massive hepatic necrosis, liver failure, and death (1-2).

Altmetrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

How to Cite



Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. (2008). Reumatismo, 60(1), 22-27. https://doi.org/10.4081/reumatismo.2008.22

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.